Health Care: Drugs

Pacific Biosciences of California Inc (PACB: NASDAQ)

$5.2 -0.21 | -3.88%
07/02/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 60.59M 28.18M 25.98M 33.86M
Cost of Sales 32.18M 15.52M 18.39M 15.03M
Gross Operating Profit 28.42M 12.66M 7.59M 18.84M
Selling, General, and Administrative Expenses 38.03M 38.74M 47.66M 46.71M
Research & Development 48.23M 45.22M 47.62M 76.08M
Operating Income before D & A (EBITDA) -57.84M -71.30M -87.69M -103.95M
Depreciation & Amortization 5.01M 6.24M 6.65M 5.80M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -478.00K 728.00K -127.00K 368.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -63.33M -76.82M -94.46M -109.39M
Interest Expense 2.83M 2.48M 0.00 0.00
Pre-Tax Income -66.16M -79.29M -94.46M -109.39M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -66.16M -79.29M -94.46M -109.39M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -66.16M -79.29M -94.46M -109.39M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -66.16M -79.29M -94.46M -109.39M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-66.16M -79.29M -94.46M -109.39M
Preferred Dividends
Net Income Available To Common -66.16M -79.29M -94.46M -109.39M
Basic EPS from Continuing Ops. -0.94 -1.26 -1.69 -2.03
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.94 -1.26 -1.69 -2.03
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.94 -1.26 -1.69 -2.03
Basic Normalized Net Income/Share -0.94 -1.26 -1.69 -2.03
EPS fr Continuing Ops. -0.94 -1.26 -1.69 -2.03
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.94 -1.26 -1.69 -2.03
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.94 -1.26 -1.69 -2.03
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.94 -1.26 -1.69 -2.03
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with PACB

Latest PACB Headlines from TheStreet

More Financial News for PACB

Press Releases for PACB

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter